Your browser doesn't support javascript.

Portal de Pesquisa da BVS

Informação e Conhecimento para a Saúde

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:


Adicionar mais destinatários
| |

The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: A case-control study.

Fernandes, Eder Gatti; Sato, Ana Paula S; Vaz-de-Lima, Lourdes R A; Rodrigues, Marcela; Leite, Daniela; de Brito, Cyro A; Luna, Expedito J A; Carvalhanas, Telma Regina M P; Ramos, Maria Lígia Bacciote Nerger; Sato, Helena Keico; de Castilho, Euclides A.
Vaccine; 2019 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-30948222


In 2014, the Brazilian Ministry of Health (MoH) recommended Tdap to pregnant women in response to a significant increase in the incidence of pertussis among infants. The present study assessed the effectiveness of maternal immunization in preventing pertussis in infants.


An unmatched case-control study was undertaken in São Paulo State, Brazil from February 2015 to July 2016. Cases were infants aged <8 weeks at onset of pertussis reported to the Surveillance System and confirmed by real-time polymerase chain reaction or culture. Four to six healthy infants were selected as controls per case from birth certificates in the Information System on Live Births database. General characteristics and mother's vaccination status were compared between cases and controls. The vaccine effectiveness (VE) was calculated as 1 - odds ratio (OR). For the adjusted VE, the OR was calculated using logistic regression analysis.


Forty-two cases and 248 controls were enrolled in the study. Mothers of 8 cases (19.1%) and 143 controls (57.4%) were vaccinated during pregnancy, resulting in an unadjusted VE of 82.6% (95% confidence interval [CI], 60.8-92.3%). The VE was unchanged after adjusting for maternal age and monthly household income.


Maternal pertussis vaccination during pregnancy was effective in protecting infants aged <8 weeks from pertussis.